MAP3K5 and lung cancer: As for SLC7A11-AS1, it can confer malignant progression by repressing miR-4775 and TRAIP expression in lung cancer and reduce tumor growth via the ASK1-p38 MAPK/JNK pathway in gastric cancer [32–34].